There are 2789 resources available
1585P - COVID-19 cancer patients outcomes in an intensive care setting: A case-control study
Presenter: Ridhi Ranchor
Session: ePoster Display
1665TiP - High-dose vs standard-dose thoracic radiotherapy for extensive stage small cell lung cancer: Study protocol for a phase III randomized trial
Presenter: Yufan Yang
Session: ePoster Display
1666TiP - Phase II study of berzosertib (M6620) + topotecan in patients with relapsed platinum-resistant SCLC: DDRiver SCLC 250
Presenter: Anish Thomas
Session: ePoster Display
1667TiP - Durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A Spanish phase IIIb single arm, real-world study
Presenter: Luis Paz-Ares
Session: ePoster Display
1668TiP - Phase Ib study of AMG 757, a half-life extended bispecific T-cell engager immuno-oncology therapy, combined with AMG 404, an anti-PD-1 antibody, in patients with small cell lung cancer (SCLC)
Presenter: Afshin Dowlati
Session: ePoster Display
1673P - Efficacy and safety of 5 mg olanzapine for the prevention of carboplatin-induced nausea and vomiting in patients with thoracic malignancies: A prospective multicenter phase II study
Presenter: Yukiyoshi Fujita
Session: ePoster Display
1674P - Does body mass index (BMI) affect the type of response to anamorelin (ANAM) over time? Focus on body composition and anorexia symptoms and concerns
Presenter: David Currow
Session: ePoster Display
1710P - Impact of adding plinabulin to pegfilgrastim for the prevention of chemotherapy induced neutropenia (CIN) on patient quality of life (QoL)
Presenter: Douglas Blayney
Session: ePoster Display